Mutually exclusive item pairs and similar item pairs

Page last updated: 15 July 2018

Item 1

Item 2
Reason the services cannot be requested on the same day
MBS item number
Description
(refer to www.mbsonline.gov.au for full details)
MBS item number
Description
(refer to www.mbsonline.gov.au for full details)
Iron studies.Quantitation of Ferritin.66596 includes the test described in 66593.
Quantitation of Hepatitis B viral DNA … in patients not receiving antiviral therapy.Quantitation of Hepatitis B viral DNA … in patients receiving antiviral therapy.These items are for testing at different stages of a patient’s disease management.
Quantitation of HbA1c for the diagnosis of diabetes in high risk asymptomatic patients.Quantitation of HBA1c in the management of established diabetes.These items are for testing at different stages of a patient’s disease management.
Erythrocyte count … not being a service where haemoglobin only is requested.Haemoglobin, erythrocyte sedimentation rate, blood viscosity – 1 or more tests.65070 includes the tests described in 65060.
Three tests for the diagnosis of thalassaemia …– including any service in item 65060 or 65070 Erythrocyte count, haematocrit etc …one or more65078 includes the tests described in 65070
Bone marrow trephine biopsy. including any test described in item 65060, 65066 or 65070Erythrocyte count, haematocrit etc …one or more65084 includes the tests described in 65070.
Examination of aspirated material from bone marrow including any test described in item 65060 65066 or 65070.Erythrocyte count, haematocrit etc …one or more65087 includes the tests described in 65070.
Blood grouping … including any test described in item 65060 or 65070.Erythrocyte count, haematocrit etc …one or more65096 includes the tests described in 65070.
Compatibility tests by crossmatch ... including any tests described in item 65060, 65070 or 65096.Erythrocyte count, haematocrit etc …one or more65099 includes the tests described in 65070.
Compatibility tests by crossmatch ... including any tests described in item 65060, 65070 or 65096.Blood grouping … including any test described in item 65060 or 65070.65099 includes the tests described in 65096.
Compatibility testing using at least a 3 cell panel and issue of red cells for transfusion … including any tests described in item 65060, 65070, 65090 or 65096.Erythrocyte count, haematocrit etc …one or more65105 includes the tests described in 65070.
Compatibility testing using at least a 3 cell panel and issue of red cells for transfusion … including any tests described in item 65060, 65070, 65090 or 65096.Blood grouping … including any test described in item 65060 or 65070.65105 includes the tests described in 65096.
Four or more tests described in item 65120 (associated with blood coagulation).One test associated with blood coagulation 65129 includes the tests described in 65120.
Up to two tests for the quantitation of haemostatic glycoproteins rendered by the receiving APP other than described in item 65157.Quantitation of haemostatic glycoproteins rendered by receiving APP where no tests have been rendered by the referring APP.65158 and 65157 cannot be claimed together if the referring APP has rendered at least one test described in 65150.
Up to four tests for anti-thrombin proteins rendered by the receiving APA, other than that described in 65180. One test for anti-thrombin proteins rendered by the receiving APA where no tests have been rendered by the referring APA. 65181 and 65180 cannot be claimed together if the referring APP has rendered at least one test described in 65175.
Two tests used in the quantitation of bio-chemicals and proteins in the serum and other body fluids.One test used in the quantitation of bio-chemicals and proteins in serum and other body fluids.66503 includes the tests described in 66500.
Five or more tests used in the quantitation of biochemical and proteins in the serum and other body fluids.One test used in the quantitation of bio-chemicals and proteins in serum and other body fluids.66512 includes the tests described in 66500.
Five or more tests used in the quantitation of biochemical and proteins in the serum and other body fluids.Two tests used in the quantitation of bio-chemicals and proteins in the serum and other body fluids.Both items include tests described in item 66500.
Five or more tests used in the quantitation of biochemical and proteins in the serum and other body fluids.Three tests used in the quantitation of bio-chemicals and proteins in serum and other body fluids.Both items include tests described in item 66500.
Five or more tests used in the quantitation of biochemical and proteins in the serum and other body fluids.Four tests used in the quantitation of bio-chemicals and proteins in serum and other body fluids.Both items include tests described in item 66500.
Quantitation of HbA1c in pregnant patients with pre-existing diabetes including a service in item 66551Quantitation of HbA1c in the management of established diabetes.66554 includes the test described in 66551.
Quantitation of blood gases, bicarbonate and pH - two specimens performed in one day. One specimen used for the quantitation of blood gases, bicarbonate and pH and other measurements (e.g. lactate).66569 includes the tests described in 66566.
Quantitation of blood gases, bicarbonate and pH - three specimens performed in one day.One specimen used for the quantitation of blood gases, bicarbonate and pH and other measurements (e.g. lactate).66572 includes the tests described in 66566.
Two or more tests of cancer protein indicators for the monitoring of malignancy or detection/monitoring of hepatic tumours, gestational trophoblastic disease or germ cell tumour. One test of cancer protein indicators for the monitoring of malignancy or detection/monitoring of hepatic tumours, gestational trophoblastic disease or germ cell tumour. 66653 includes the tests described in 66650.
Quantitation of PSA (including test associated with item 66656) where previous PSA results lies at or above 97.5% reference limit.Quantitation of PSA in the monitoring of previously diagnosed prostate disease.66659 includes test described in 66656.
Up to 4 quantitation tests of hormones and hormone binding proteins in blood or urine (other than 66696) rendered by a receiving APP. One quantitation test of hormones and hormone binding proteins in blood or urine, rendered by receiving APP where no tests in the item have been rendered by the referring APP. 66697 and 66696 cannot be claimed together if the referring APP has rendered at least one test described in 66695.
2 tests described in item 66695.One quantitation test for hormones and hormone binding proteins in blood or urine. 66698 includes the tests described in 66695.
3 tests described in item 66695.One quantitation test for hormones and hormone binding proteins in blood or urine.66701 includes the tests described in 66695.
3 tests described in item 66695.Two tests described in item 66695Both items refer to the tests described in 66695. Item 66707 maybe more appropriate.
4 tests described in item 66695.One quantitation test for hormones and hormone binding proteins in blood or urine.66704 includes the tests described in 66695.
5 or more tests described in item 66695.One quantitation test for hormones and hormone binding proteins in blood or urine.66707 includes the tests described in 66695.
Thyroid function test.TSH quantitation.66719 includes 66716.
TSH quantitation and 1 test described in item 66695.One quantitation test for hormones and hormone binding proteins in blood or urine.66722 includes one test described in 66695.
TSH quantitation and 1 test described in item 66695.TSH quantitation.66722 includes 66716.
TSH quantitation and 5 tests described in item 66695. One quantitation test for hormones and hormone binding proteins in blood or urine.66734 includes the tests described in 66695.
TSH quantitation and 5 tests described in item 66695 (hormones and hormone binding proteins in blood or urine).TSH quantitation.66734 includes 66716.
Two tests described in item 66812. One therapeutic drug quantitation test in blood, urine or other body fluid. 66815 includes the tests described in 66812.
One test described in item 66812 (therapeutic drug quantitation test in blood, urine or other body fluid) other than item 66816, if rendered by the receiving APP.Therapeutic drug quantitation test described in item 66812 by the receiving APP (where no tests in the item have been rendered by the referring APP) – one test.66817 and 66816 cannot be claimed together if the referring APP has rendered at least one test described in 66812.
One quantitation test of item 66819 (copper, magnesium… in blood, urine or other body fluid), rendered by a receiving APP, other than that described in 66820.One quantitation test of item 66819 (copper, magnesium… in blood, urine or other body fluid), rendered by a receiving APP where no tests have been rendered by the referring APP. 66821 excludes 66820.
One test described in item 69494 and a test described in 69316. On test to detect Chlamydia trachomatis.69317 includes 69316.
One test described in item 69494 and a test described in 69316.One test to detect virus or microbial antigen or microbial nucleic acid. 69317 includes 69494.
Microscopy and culture to detect pathogens from sputum (except when part of items 69324, 69327 and 69330)… Microscopy (with appropriate stains) and culture for mycobacteria from one specimen of sputum… 69318 cannot be rendered if the test is part of 69324.
Microscopy and culture to detect pathogens from sputum (except when part of items 69324, 69327 and 69330)…Microscopy (with appropriate stains) and culture for mycobacteria from two specimens of sputum…69318 cannot be rendered if the test is part of 69327.
Microscopy and culture to detect pathogens from sputum (except when part of items 69324, 69327 and 69330)...Microscopy (with appropriate stains) and culture for mycobacteria from three specimens of sputum…69318 cannot be rendered if the test is part of 69330.
2 tests described in item 69494 and a test described in 69316.One test to detect Chlamydia trachomatis.69319 includes the tests described in 69316.
2 tests described in item 69494 and a test described in 69316.One test described in item 69494 and a test described in 69316.69319 includes the tests described in 69317.
2 tests described in item 69494 and a test described in 69316.One test to detect virus or microbial antigen or microbial nucleic acid. 69319 includes the tests described in 69494.
Microscopy and culture of post-operative wounds… operative or biopsy specimens… including a service described in item 69300, 69303, 69306, 69312 or 69318Microscopy and culture to detect pathogenic micro-organisms from skin or other superficial sites…69321 includes the tests described in 69306.
2 sets of cultures described in item 69354.Blood culture for pathogenic micro-organisms. 69357 includes the tests described in 69354.
Detection of Clostridium difficile or Clostridium difficile toxin (except if a service described in item 69345 has been performed).Culture and microscopy for faecal pathogens69363 cannot be rendered if item 69345 has been performed.
Two tests described in 69384.Quantitation of 1 antibody to microbial antigens – one test.69387 includes the tests described in 69384
Two hepatitis serology testsOne hepatitis serology test 69478 includes the tests described in 69475.
Quantitation of HCV RNA for pre-treatment evaluation…or assessment of efficacy of antiviral therapy (including a service in 69499 or 69445)Detection of HCV RNA in patients undertaking antiviral therapy.69488 includes the tests described in 69445
Quantitation of HCV RNA for pre-treatment evaluation…or assessment of efficacy of antiviral therapy (including a service in 69499 or 69445)Detection of Hepatitis C viral RNA69488 includes the tests described in 69499.
3 or more tests described in 69494.One test to detect virus or microbial antigen or microbial nucleic acid.69496 includes the tests described in 69494.
3 or more tests described in 69494.2 tests described in 69494.Both items includes tests described in 69494
Up to 2 tests described in item 69494, other than that described in 69497, if rendered by a receiving APP.One test described in item 69494, if rendered by a receiving APP, where no tests in the item have been rendered by the referring APP.69498 and 69497 cannot be claimed together if the referring APP has rendered at least one test described in 69494.
Tests to investigate the assessment or diagnosis of systemic inflammatory disease or vasculitis (item 71153), other than that described in 71154, if rendered by a receiving APP.A test to investigate the assessment or diagnosis of systemic inflammatory disease or vasculitis (item 71153), if rendered by a receiving APP, where no tests in the item have been rendered by the referring APP. 71156 and 71154 cannot be claimed together if the referring APP has rendered at least one test described in 71153.
Two or more tests described in 71163 and including a service described in 71066 (if performed). One test to detect antibodies in the assessment or diagnosis of coeliac disease or other gluten hypersensitivity syndromes…
71164 includes the tests described in 71163.
Detection of 2 antibodies described in item 71165.Detection, including quantitation if required, of one antibody to tissue antigens…71166 includes the tests described in 71165.
Tests described in item 71165 (quantitation of antibody to tissue antigens…), other than that described in 71169, if rendered by a receiving APP. A test described in item 71165 (quantitation of antibody to tissue antigens...), if rendered by a receiving APP, where no tests in the item have been rendered by the referring APP.71170 and 71169 cannot be claimed together if the referring APP has rendered at least one test described in 71165.
Examination of complexity level 3 biopsy material… 2 to 4 separately identified specimen. Examination of complexity level 3 biopsy material... – one specimen.
72817 includes the test described in 72816.
Cytology for malignancy…( other than an examination mentioned in 73053 [pre-31 January 2018])
73053
Cytology of cervical smear…for the detection of pre-cancerous or cancerous changes…73045 can only be claimed when 73053 (deleted 31 Jan 2018) does not apply.